跳至主要内容
临床试验/EUCTR2016-004277-41-GB
EUCTR2016-004277-41-GB进行中(未招募)1 期

An observational study into the variety of electrocardiographic responses to an ajmaline Provocation in healthy subjects. What are the genetic and structural variations dictating this response ? - The Response To Ajmaline Provocation in Healthy Subjects

St George's University of London0 个研究点目标入组 100 人开始时间: 2020年8月17日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Asymptomatic healthy individuals
  • Aged 18-65
  • Kidney function = 30ml/min/1.73m2
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 0
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Any prior cardiovascular illness
  • Previous cardiac symptoms.
  • History of unexplained syncope
  • Any family history of proven sudden cardiac death or unexplained sudden death either in adulthood or infancy.
  • Those unable to provide a two generation family history
  • Abnormal resting ECG
  • Abnormal screening cardiac ultrasound
  • Any contraindications to cardiac magnetic resonance imaging participant has cardiac pacemaker; recent surgery; vascular clips; metal implants or joint replacements; have had metal fragments in their eyes; has ever worked on a lathe; has shrapnel from a war injury
  • Known allergy e.g. seafood, hayfever, hives
  • Pregnant or breastfeeding women
  • Male or pre-menopausal female participants of child-bearing potential* unwilling to use an effective method of birth control (either hormonal in the form of the contraceptive pill or barrier method of birth control accompanied by the use of a proprietary spermicidal foam/gel or film ; or agreement of true abstinence (i.e. withdrawal, calendar, ovulation, symptothermal and post ovulation are not acceptable methods) from time consent is signed until 6 weeks after the last dose of IMP
  • Enrolled on another CTIMP study
  • Intercurrent use of any medication known to be contraindicated in Brugada Syndrome
  • Any contraindication to ajmaline Provocation as detailed in the approved St George’s Hospital clinical ajmaline protocol.
  • *Subjects are only considered not of child bearing potential if they are surgically sterile (i.e. they have undergone a hysterectomy, bilateral tubal ligation, or bilateral oophorectomy) or they are postmenopausal

研究者

相似试验

A study of the hearts response to the drug Ajmaline... | 临床试验